{"id":57488,"date":"2024-02-27T17:46:46","date_gmt":"2024-02-27T17:46:46","guid":{"rendered":"https:\/\/medsname.com\/stanhep-25-heparin-sodium-injection\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"stanhep-25-heparin-sodium-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/stanhep-25-heparin-sodium-injection\/","title":{"rendered":"Stanhep 25 Heparin-n\u00e1trium injekci\u00f3"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Quick Answer \u2014 What is Stanhep 25?<\/h3>\n<p style=\"margin:0;\"><strong>Stanhep 25<\/strong> is 25,000 IU per 5 mL vial unfractionated heparin sodium injection from a WHO-GMP certified manufacturer \u2014 an indirect parenteral anticoagulant administered by IV infusion or subcutaneous injection in hospital. Heparin works by potentiating antithrombin, which then inactivates thrombin (IIa) and factor Xa. Onset is immediate (IV) and the half-life is short (60-90 min) \u2014 making it the anticoagulant of choice when rapid onset, rapid offset, and protamine reversal matter (acute coronary syndrome, peri-operative bridging, dialysis, renal failure where LMWH accumulates). Dose is weight-based and titrated to aPTT 1.5-2.5x baseline or anti-Xa 0.3-0.7 IU\/mL. The major life-threatening complication is heparin-induced thrombocytopenia (HIT), an immune reaction usually appearing on day 5-10. Reversal: protamine sulfate. This is a hospital-only product administered under medical supervision \u2014 not for self-injection. For at-home VTE prophylaxis or treatment most patients now receive low-molecular-weight heparin (enoxaparin, dalteparin) or a DOAC.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>Hospital-only IV\/SC anticoagulant.<\/strong> Hospital-only IV\/SC anticoagulant.<\/div>\n<h2 class=\"wp-block-heading\">Mi a Stanhep 25?<\/h2>\n<p>A Stanhep 25 frakcion\u00e1latlan heparin (UFH) n\u00e1trium 25 000 IU\/5 mL injekci\u00f3s \u00fcveg, WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3t\u00f3l, 1-10 \u00fcveges kiszerel\u00e9sben. Az UFH a klinikai gyakorlatban az 1930-as \u00e9vek \u00f3ta haszn\u00e1lt protot\u00edpus parenter\u00e1lis antikoagul\u00e1ns. Az LMWH \u00e9s a DOAC el\u0151ret\u00f6r\u00e9se ellen\u00e9re kulcsszerepet t\u00f6lt be, ahol a gyors hat\u00e1s, a gyors megsz\u0171n\u00e9s \u00e9s a protaminnal val\u00f3 visszaford\u00edthat\u00f3s\u00e1g fontos.<\/p>\n<h2 class=\"wp-block-heading\">Hogyan m\u0171k\u00f6dik a heparin?<\/h2>\n<p>A heparin antithrombin III-hoz k\u00f6t\u0151dik pentaszacharid szekvenci\u00e1j\u00e1n kereszt\u00fcl, \u00e9s kb. 1000-szeres\u00e9re gyors\u00edtja az antithrombin thrombin (IIa faktor) \u00e9s Xa faktor g\u00e1tl\u00e1s\u00e1t. Az UFH nagyj\u00e1b\u00f3l egyform\u00e1n g\u00e1tolja a IIa \u00e9s Xa faktorokat; az LMWH-k el\u0151nyben r\u00e9szes\u00edtik az Xa g\u00e1tl\u00e1s\u00e1t. IV bead\u00e1skor a hat\u00e1s azonnali; subkut\u00e1n bead\u00e1skor 20-30 perc. A plazma felez\u00e9si ideje 60-90 perc, d\u00f3zisf\u00fcgg\u0151, ami lehet\u0151v\u00e9 teszi a gyors hat\u00e1s megsz\u0171n\u00e9s\u00e9t.<\/p>\n<h2 class=\"wp-block-heading\">J\u00f3v\u00e1hagyott alkalmaz\u00e1si ter\u00fcletek<\/h2>\n<ul>\n<li><strong>Akut coronariaszindr\u00f3ma (NSTEMI \/ instabil angina, STEMI)<\/strong> \u2014 antiaggreg\u00e1nsokkal \u00e9s PCI-vel<\/li>\n<li><strong>Akut v\u00e9n\u00e1s thromboemb\u00f3lia (m\u00e9lyv\u00e9n\u00e1s thrombosis, t\u00fcd\u0151emb\u00f3lia)<\/strong> \u2014 k\u00fcl\u00f6n\u00f6sen, ha alacsony molekulat\u00f6meg\u0171 heparin nem alkalmazhat\u00f3 (s\u00falyos veseelegtelens\u00e9g, tervezett beavatkoz\u00e1sok)<\/li>\n<li><strong>Perioperat\u00edv \u00e1tmeneti anticoagul\u00e1ci\u00f3<\/strong> m\u0171t\u00e9tre ker\u00fcl\u0151, hossz\u00fa t\u00e1v\u00fa anticoagul\u00e1ci\u00f3ban r\u00e9szes\u00fcl\u0151 betegekn\u00e9l<\/li>\n<li><strong>Sz\u00edv-l\u00e9gz\u00e9si bypass \u00e9s ECMO \u00e1ramk\u00f6r\u00f6k<\/strong><\/li>\n<li><strong>Folyamatos vesep\u00f3tl\u00f3 kezel\u00e9s (CRRT) \u00e9s hemodial\u00edzis<\/strong> \u2014 \u00e1ramk\u00f6r anticoagul\u00e1ci\u00f3<\/li>\n<li><strong>Kat\u00e9ter \u00e9s vonal patenci\u00e1ja<\/strong> \u2014 alacsony d\u00f3zis\u00fa \u00f6bl\u00edt\u00e9s (k\u00fcl\u00f6n, alacsonyabb hat\u00f3anyag-tartalm\u00fa k\u00e9sz\u00edtm\u00e9nyek)<\/li>\n<li><strong>Pitvarfibrill\u00e1ci\u00f3 kardioverzi\u00f3s \u00e1tmeneti anticoagul\u00e1ci\u00f3<\/strong><\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">D\u00f3zis \u00e9s monitoroz\u00e1s<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 22px 0;font-size:14px;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;\">Agoprex is a 25 mg agomelatine tablet supplied by Sun Pharma. Agomelatine is mechanistically unique among antidepressants: it acts as an agonist at melatonin MT1 and MT2 receptors and an antagonist at 5-HT2C serotonin receptors. The dual mechanism resynchronises disrupted circadian rhythms (a feature of major depression) while indirectly increasing dopamine and noradrenaline release in the frontal cortex.<\/th>\n<th style=\"padding:8px;text-align:left;\">Terhel\u0151 adag<\/th>\n<th style=\"padding:8px;text-align:left;\">Karbantart\u00f3 adag<\/th>\n<th style=\"padding:8px;text-align:left;\">Indications and dosing<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;\">Akut v\u00e9n\u00e1s thromboemb\u00f3lia (kezel\u00e9s)<\/td>\n<td style=\"padding:8px;\">80 NE\/kg intrav\u00e9n\u00e1s bolus<\/td>\n<td style=\"padding:8px;\">18 NE\/kg\/\u00f3ra intrav\u00e9n\u00e1s inf\u00fazi\u00f3<\/td>\n<td style=\"padding:8px;\">aPTT 1,5\u20132,5\u00d7 alap\u00e9rt\u00e9k<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">ACS<\/td>\n<td style=\"padding:8px;\">60 NE\/kg (max 4000 NE)<\/td>\n<td style=\"padding:8px;\">12 NE\/kg\/\u00f3ra (max 1000 NE\/\u00f3ra)<\/td>\n<td style=\"padding:8px;\">aPTT 50\u201370 mp<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">SC profilaxis<\/td>\n<td style=\"padding:8px;\">\u2014<\/td>\n<td style=\"padding:8px;\">5000 NE SC 8\u201312 \u00f3r\u00e1nk\u00e9nt<\/td>\n<td style=\"padding:8px;\">Rutinmonitoroz\u00e1s nem sz\u00fcks\u00e9ges<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Sz\u00edv-t\u00fcd\u0151 bypass<\/td>\n<td style=\"padding:8px;\">300\u2013400 NE\/kg IV<\/td>\n<td style=\"padding:8px;\">\u00dajrad\u00f3z\u00e1s az ACT fenntart\u00e1s\u00e1hoz<\/td>\n<td style=\"padding:8px;\">ACT &gt;480 mp<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Az aPTT vagy anti-Xa (0,3\u20130,7 IU\/mL) monitoroz\u00e1sa 6 \u00f3r\u00e1nk\u00e9nt a kezd\u00e9s vagy d\u00f3zism\u00f3dos\u00edt\u00e1s ut\u00e1n, majd stabil \u00e1llapotban naponta. Alapvonal FBC, PT, aPTT, fibrinog\u00e9n, vese- \u00e9s m\u00e1jfunkci\u00f3 ellen\u0151rz\u00e9se.<\/p>\n<h2 class=\"wp-block-heading\">Heparin-induk\u00e1lt trombocitopenia (HIT)<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>HIT gyan\u00faja<\/strong> ha a trombocitasz\u00e1m &gt;50%-kal cs\u00f6kken az alap\u00e9rt\u00e9khez k\u00e9pest (vagy &lt;100\u00d710<sup>9<\/sup>\/L) \u00e1ltal\u00e1ban a heparin 5-10. napj\u00e1n (vagy kor\u00e1bban kor\u00e1bbi heparin expoz\u00edci\u00f3 eset\u00e9n). A HIT paradox pro-trombotikus immunreakci\u00f3 (anti-PF4\/heparin antitestek) \u00e9s 30-50% thrombosis kock\u00e1zattal j\u00e1r. Int\u00e9zked\u00e9s: MINDEN heparin (bele\u00e9rtve az \u00f6bl\u00edt\u00e9seket) AZONNALI LE\u00c1LL\u00cdT\u00c1SA, warfarin KER\u00dcL\u00c9SE a trombocit\u00e1k helyre\u00e1ll\u00edt\u00e1s\u00e1ig, \u00e9s nem heparin alap\u00fa antikoagul\u00e1ns (argatroban, danaparoid, fondaparinux vagy bivalirudin) kezd\u00e9se. Meger\u0151s\u00edt\u00e9s anti-PF4 ELISA \u00e9s szerotonin felszabadul\u00e1si teszt seg\u00edts\u00e9g\u00e9vel. A 4Ts pontsz\u00e1m a klinikai val\u00f3sz\u00edn\u0171s\u00e9get ir\u00e1ny\u00edtja.<\/div>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<ul>\n<li>V\u00e9rz\u00e9s (nagyobb v\u00e9rz\u00e9si ar\u00e1ny ~5% ter\u00e1pi\u00e1s intrav\u00e9n\u00e1s heparin mellett)<\/li>\n<li>Heparin-induk\u00e1lt trombocitopenia (HIT) \u2014 II. t\u00edpus\u00fa, immunmedi\u00e1lt, \u00e9letvesz\u00e9lyes<\/li>\n<li>Enyhe, j\u00f3indulat\u00fa trombocitasz\u00e1m-cs\u00f6kken\u00e9s (HIT I. t\u00edpus, nem immun, \u00e1tmeneti)<\/li>\n<li>Hyperkalaemia (aldoszteron g\u00e1tl\u00e1s, k\u00fcl\u00f6n\u00f6sen cukorbetegs\u00e9gben \u00e9s veseel\u00e9gtelens\u00e9gben)<\/li>\n<li>Osteoporosis hossz\u00fa t\u00e1v\u00fa (&gt;3 h\u00f3napos) haszn\u00e1lat mellett<\/li>\n<li>Injekci\u00f3 hely\u00e9n fell\u00e9p\u0151 z\u00faz\u00f3d\u00e1s\/hemat\u00f3ma (SC \u00faton)<\/li>\n<li>T\u00fal\u00e9rz\u00e9kenys\u00e9gi reakci\u00f3k, ritk\u00e1n anafilaxia<\/li>\n<li>M\u00e1jenzimek emelked\u00e9se<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Ellenjavallatok<\/h2>\n<ul>\n<li>Akt\u00edv s\u00falyos v\u00e9rz\u00e9s<\/li>\n<li>Ismert HIT vagy HIT el\u0151zm\u00e9ny (haszn\u00e1ljon nem-heparin alap\u00fa antikoagul\u00e1nst)<\/li>\n<li>S\u00falyos trombocitopenia (trombocit\u00e1k &lt;50\u00d710<sup>9<\/sup>\/L)<\/li>\n<li>S\u00falyos, kontroll\u00e1latlan hypertonia<\/li>\n<li>Friss intrakrani\u00e1lis, szem\u00e9szeti vagy nagyobb v\u00e9rz\u00e9si kock\u00e1zattal j\u00e1r\u00f3 m\u0171t\u00e9t<\/li>\n<li>Peptikus fek\u00e9ly akt\u00edv v\u00e9rz\u00e9ssel, nyel\u0151cs\u0151-varix<\/li>\n<li>Heparin vagy sert\u00e9startalm\u00fa term\u00e9kekre \u00e9rz\u00e9kenys\u00e9g<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<ul>\n<li><strong>Egy\u00e9b antikoagul\u00e1nsok\/antiaggreg\u00e1nsok<\/strong> (varfarin, DOAC-ok, aszpirin, klopidogrel, NSAID-k, fibrinolitikumok) \u2014 kumulat\u00edv v\u00e9rz\u00e9si kock\u00e1zat; csak szakorvosi fel\u00fcgyelettel \u00e9s klinikai indik\u00e1ci\u00f3 eset\u00e9n kombin\u00e1lhat\u00f3.<\/li>\n<li><strong>Gliceril-trinitr\u00e1t IV inf\u00fazi\u00f3<\/strong> \u2014 cs\u00f6kkentheti a heparin hat\u00e1s\u00e1t; aPTT monitoroz\u00e1s szok\u00e1s szerint.<\/li>\n<li><strong>SSRI-k\/SNRI-k<\/strong> \u2014 enyh\u00e9n fokozott v\u00e9rz\u00e9si kock\u00e1zat.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Semleges\u00edt\u00e9s: Protamin-szulf\u00e1t<\/h2>\n<p>S\u00falyos v\u00e9rz\u00e9s vagy s\u00fcrg\u0151s semleges\u00edt\u00e9s eset\u00e9n a protamin-szulf\u00e1t semleges\u00edti a heparint: 1 mg protamin 100 IU heparinra az elm\u00falt 2-3 \u00f3r\u00e1ban beadott mennyis\u00e9gb\u0151l, lass\u00fa IV (max 50 mg 10 perc alatt) a hypot\u00f3nia \u00e9s anafilaktoid reakci\u00f3k elker\u00fcl\u00e9se \u00e9rdek\u00e9ben. Maxim\u00e1lis egyszeri adag 50 mg; aPTT ellen\u0151rz\u00e9se 5-15 perc ut\u00e1n. Magasabb a protamin-reakci\u00f3 kock\u00e1zata olyan betegekn\u00e9l, akik kor\u00e1bban NPH inzulint kaptak, halallergi\u00e1sak vagy vazekt\u00f3mi\u00e1n estek \u00e1t.<\/p>\n<h2 class=\"wp-block-heading\">Terhess\u00e9g \u00e9s szoptat\u00e1s<\/h2>\n<p>A heparin \u00e9s LMWH nem jut \u00e1t a m\u00e9hlep\u00e9nyen, \u00e9s a terhess\u00e9g alatti els\u0151dleges antikoagul\u00e1nsok. LMWH az el\u0151nyben r\u00e9szes\u00edtett ambul\u00e1ns kezel\u00e9shez. Szoptat\u00e1s: a heparin nem v\u00e1lik ki az anyatejbe (nagy molekula) \u2014 biztons\u00e1gos.<\/p>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<p>A Stanhep 25-\u00f6t 25\u00b0C alatt t\u00e1rolja, ne fagyassza. Ha egy flakon m\u00e1r fel van nyitva, k\u00f6vesse az int\u00e9zm\u00e9nyi steriliz\u00e1ci\u00f3s protokollokat. Tartsa gyermekekt\u0151l el\u00e9rhetetlen helyen.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Haszn\u00e1lhatom a Stanhep 25-\u00f6t otthon?<\/h3>\n<p>Nem. A Stanhep 25 magas hat\u00f3anyag-tartalm\u00fa, t\u00f6bbsz\u00f6r\u00f6s adagol\u00e1s\u00fa flakon (25 000 NE\/5 ml), amelyet k\u00f3rh\u00e1zi intrav\u00e9n\u00e1s inf\u00fazi\u00f3ra vagy fekv\u0151beteg subcut\u00e1n adagol\u00e1s\u00e1ra sz\u00e1nnak aPTT vagy anti-Xa monitoroz\u00e1s mellett. Az otthoni antikoagul\u00e1ci\u00f3ra \u00e1ltal\u00e1ban LMWH-t (enoxaparin, dalteparin) vagy DOAC-ot haszn\u00e1lnak.<\/p>\n<h3 class=\"wp-block-heading\">Mi a k\u00fcl\u00f6nbs\u00e9g a heparin \u00e9s az LMWH k\u00f6z\u00f6tt?<\/h3>\n<p>A frakcion\u00e1latlan heparin (UFH) heterog\u00e9n kever\u00e9k, amely egyform\u00e1n g\u00e1tolja a IIa \u00e9s Xa t\u00e9nyez\u0151ket, r\u00f6vid felez\u00e9si id\u0151vel rendelkezik \u00e9s aPTT monitoroz\u00e1st ig\u00e9nyel. Az LMWH-k (enoxaparin, dalteparin) kisebb molekul\u00e1k, el\u0151nyben g\u00e1tolj\u00e1k a Xa t\u00e9nyez\u0151t, hosszabb, kisz\u00e1m\u00edthat\u00f3 felez\u00e9si id\u0151vel rendelkeznek, a legt\u00f6bb betegn\u00e9l subcut\u00e1n adhat\u00f3ak monitoroz\u00e1s n\u00e9lk\u00fcl, \u00e9s els\u0151vonalbeli v\u00e1laszt\u00e1s ambul\u00e1ns kezel\u00e9sre. Az UFH el\u0151ny\u00f6sebb, ha gyors hat\u00e1smegsz\u0171n\u00e9s, s\u00falyos veseel\u00e9gtelens\u00e9g vagy protaminnal val\u00f3 reverzibilit\u00e1s sz\u00fcks\u00e9ges.<\/p>\n<h3 class=\"wp-block-heading\">Mi a HIT \u00e9s hogyan kezelik?<\/h3>\n<p>A heparin-induk\u00e1lt trombocitop\u00e9nia immunreakci\u00f3 (anti-PF4\/heparin antitestek), amely \u00e1ltal\u00e1ban a heparin kezel\u00e9s 5-10. napj\u00e1n jelentkezik, paradox m\u00f3don pro-trombotikus \u00e1llapotot okozva. Minden heparin (bele\u00e9rtve az \u00f6bl\u00edt\u00e9seket) azonnali abbahagy\u00e1sa sz\u00fcks\u00e9ges, ker\u00fclni kell a varfarint a trombocit\u00e1k helyre\u00e1ll\u00edt\u00e1s\u00e1ig, \u00e9s nem heparin alap\u00fa antikoagul\u00e1nst kell alkalmazni (argatroban, danaparoid, fondaparinux vagy bivalirudin). Az anti-PF4 ELISA \u00e9s szerotonin-felszabad\u00edt\u00e1si teszt seg\u00edts\u00e9g\u00e9vel er\u0151s\u00edthet\u0151 meg a diagn\u00f3zis.<\/p>\n<h3 class=\"wp-block-heading\">Hogyan lehet a heparint semleges\u00edteni?<\/h3>\n<p>Protamin-szulf\u00e1t. 1 mg 100 NE heparinra, amelyet az el\u0151z\u0151 2-3 \u00f3r\u00e1ban adtak, lass\u00fa intrav\u00e9n\u00e1san. Maxim\u00e1lis egyszeri adag 50 mg. Az aPTT ellen\u0151rz\u00e9se 5-15 perc m\u00falva.<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt kell az aPTT-t monitorozni?<\/h3>\n<p>Az UFH d\u00f3zisv\u00e1lasz kisz\u00e1m\u00edthatatlan, mivel v\u00e1ltoz\u00f3 m\u00e9rt\u00e9kben k\u00f6t\u0151dik a plazmafeh\u00e9rj\u00e9khez. Az aPTT a bels\u0151 \u00fatvonal\u00fa antikoagul\u00e1ci\u00f3t t\u00fckr\u00f6zi; a ter\u00e1pi\u00e1s antikoagul\u00e1ci\u00f3 c\u00e9l\u00e9rt\u00e9ke 1,5-2,5\u00d7 az alap\u00e9rt\u00e9k (\u00e1ltal\u00e1ban 50-70 m\u00e1sodperc). Az anti-Xa (0,3-0,7 IU\/mL) az alternat\u00edv c\u00e9l\u00e9rt\u00e9k, ahol ez el\u00e9rhet\u0151.<\/p>\n<h3 class=\"wp-block-heading\">Biztons\u00e1gos a heparin terhess\u00e9g alatt?<\/h3>\n<p>Igen \u2014 a heparin (\u00e9s az LMWH) nem jut \u00e1t a m\u00e9hlep\u00e9nyen, \u00e9s az antikoagul\u00e1nsok k\u00f6z\u00fcl az els\u0151 v\u00e1laszt\u00e1s, ha antikoagul\u00e1ci\u00f3ra van sz\u00fcks\u00e9g terhess\u00e9g alatt. A varfarin teratog\u00e9n; a DOAC-okra vonatkoz\u00f3an nincs terhess\u00e9gi adat.<\/p>\n<h3 class=\"wp-block-heading\">Okozhat-e heparin hiperk\u00e1li\u00e9m\u00e1t?<\/h3>\n<p>Igen \u2014 k\u00fcl\u00f6n\u00f6sen cukorbetegs\u00e9gben \u00e9s veseel\u00e9gtelens\u00e9gben, az aldoszteron-g\u00e1tl\u00e1s miatt. Ellen\u0151rizze a k\u00e1lium szintj\u00e9t a kezel\u00e9s kezdet\u00e9n \u00e9s hosszabb ter\u00e1pia sor\u00e1n.<\/p>\n<h3 class=\"wp-block-heading\">Mi t\u00f6rt\u00e9nik, ha egy gyerek v\u00e9letlen\u00fcl lenyel egy heparin palackot?<\/h3>\n<p>A heparin sz\u00e1jon \u00e1t nem sz\u00edv\u00f3dik fel \u2014 a sz\u00e1jon \u00e1t t\u00f6rt\u00e9n\u0151 fogyaszt\u00e1s l\u00e9nyeg\u00e9ben \u00e1rtalmatlan az antikoagul\u00e1ci\u00f3 szempontj\u00e1b\u00f3l. Mindenk\u00e9ppen vigye a gyermeket a s\u00fcrg\u0151ss\u00e9gi ell\u00e1t\u00e1sra \u00e9rt\u00e9kel\u00e9s c\u00e9lj\u00e1b\u00f3l. A parenter\u00e1lis expoz\u00edci\u00f3 m\u00e1s k\u00e9rd\u00e9s.<\/p>\n<h3 class=\"wp-block-heading\">Hogyan haszn\u00e1lj\u00e1k a heparint dial\u00edzis sor\u00e1n?<\/h3>\n<p>Folyamatos inf\u00fazi\u00f3 vagy bolusz\u00far\u00e1s a dial\u00edzis \u00e1ramk\u00f6rbe megakad\u00e1lyozza a v\u00e9rr\u00f6gk\u00e9pz\u0151d\u00e9st az extracorpor\u00e1lis rendszerben. A d\u00f3zisokat az int\u00e9zm\u00e9nyi protokoll hat\u00e1rozza meg; az ACT vagy aPTT monitorozhat\u00f3 a kezel\u00e9s sor\u00e1n.<\/p>\n<h3 class=\"wp-block-heading\">Hol tudok Stanhep 25-\u00f6t v\u00e1s\u00e1rolni online?<\/h3>\n<p>A Stanhep 25-\u00f6t (25 000 IU per 5 mL palack, 1-10 palack) megv\u00e1s\u00e1rolhatja a MedsBase-t\u00f3l diszkr\u00e9t csomagol\u00e1sban \u00e9s vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1ssal. Ez k\u00f3rh\u00e1zi haszn\u00e1latra sz\u00e1nt parenter\u00e1lis term\u00e9k \u2014 k\u00e9pzett klinikusok \u00e1ltal kell beadni.<\/p>\n<h2 class=\"wp-block-heading\">Egy\u00e9b v\u00e9rr\u00f6gold\u00f3 \u00e9s v\u00e9rlemezk\u00e9gg\u00e1tl\u00f3 szerek<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/warf\/\">Warf \u2014 Warfarin 1\/2\/5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/waf-5\/\">Waf-5 \u2014 Warfarin 5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/uniwarfin\/\">Uniwarfin \u2014 Warfarin 5 mg (Unichem)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/xarelto-20\/\">Xarelto 20 \u2014 Rivaroxaban 20 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/eliquis\/\">Eliquis \u2014 Apixaban 2.5\/5 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/plavix\/\">Plavix \u2014 Clopidogrel 75 mg (Sanofi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/anti-coagulants\/\"><strong>B\u00f6ng\u00e9sszen az \u00f6sszes v\u00e9rr\u00f6gold\u00f3 \u00e9s v\u00e9rlemezk\u00e9gg\u00e1tl\u00f3 szer k\u00f6z\u00f6tt<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Orvosi nyilatkozat.<\/strong> A frakcion\u00e1latlan heparin k\u00f3rh\u00e1zi k\u00f6r\u00fclm\u00e9nyek k\u00f6z\u00f6tt alkalmazott parenter\u00e1lis antikoagul\u00e1ns, amely laborat\u00f3riumi monitoroz\u00e1st (aPTT vagy anti-Xa) \u00e9s klinikai megfigyel\u00e9st ig\u00e9nyel a HIT miatt. Nem \u00f6nbead\u00e1sra val\u00f3. Csak orvosi fel\u00fcgyelet mellett haszn\u00e1lhat\u00f3, int\u00e9zm\u00e9nyi protokoll szerinti v\u00e9rlemezkesz\u00e1m- \u00e9s aPTT-monitoroz\u00e1ssal.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>\u00c1ltal\u00e1nos eg\u00e9szs\u00e9g<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tenovate-clobetasol-cream\/\">Tenovate Clobetasol Kr\u00e9m<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/roliten\/\">Roliten<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/monolith\/\">Monolith<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/zenflox-eye-drops\/\">Zenflox szemcsepp<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/iverintas-dt-12\/\">Iverintas DT-12<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Megakad\u00e1lyozza a v\u00e9rr\u00f6gk\u00e9pz\u0151d\u00e9st<br \/>\n\u2705 Cs\u00f6kkenti a v\u00e9ralvad\u00e1s kock\u00e1zat\u00e1t<br \/>\n\u2705 Kezeli a tromb\u00f3zist<br \/>\n\u2705 Minimaliz\u00e1lja az emb\u00f3lia kock\u00e1zat\u00e1t<br \/>\n\u2705 Jav\u00edtja a v\u00e9rkering\u00e9st<\/p>\n<p>A Stanhep 25 Heparin N\u00e1triumot tartalmaz.<\/p>","protected":false},"featured_media":57489,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3635,3141,3342],"product_tag":[4311,4312],"class_list":{"0":"post-57488","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-coagulants","7":"product_cat-category-overview","8":"product_cat-general-health","9":"product_tag-heparin-sodium","10":"product_tag-stanhep","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/57488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=57488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/57489"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=57488"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=57488"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=57488"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=57488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}